Healthcare - Cancer Research
- 1040.919
- +6.103+0.59%
20min DelayTrading Jan 3 13:38 AET
1042.507High1030.880Low
1034.816Open1034.816Pre Close49.35MVolume3RiseLossP/E (Static)101.06MTurnover2Flatline0.55%Turnover Ratio150.42BMarket Cap1Fall147.21BFloat Cap
• U.S. stocks close lower, reversing earlier gains on Thursdays.
• Australian equities commence trading on an upbeat note on Friday, driven by surge in energy stocks due to boost in oil prices.
• Stocks to watch: IMU, LTM, etc.
Wall Street Summary
Stocks closed lower on Thursday, reversing gains made at the start of the new year. The $Dow Jones Industrial Average (.DJI.US)$closed do...
Top losers: $Telix Pharmaceuticals Ltd (TLX.AU)$, $Technology One Ltd (TNE.AU)$ and $Neuren Pharmaceuticals Ltd (NEU.AU)$
$S&P/ASX 200 (.XJO.AU)$ kicks off the new year with a broad rally, climbing 0.52% to close at 8,201.2 points.
10 out of 11 sectors close higher. This strong start across most sect...
Top losers: $BSP Financial Group Ltd (BFL.AU)$, $Auckland International Airport Ltd (AIA.AU)$ and $Tabcorp Holdings Ltd (TAH.AU)$
The Australian share market declined slightly on Friday, reversing the gains made earlier in this week that had led to two record highs. The $S&P/ASX 200 (.XJO.AU)$ dropped by 0...
Immutep Ltd (AU:IMM) has released an update.
Immutep Limited announced that all resolutions proposed at their 2024 Annual General Meeting were successfully passed, showcasing strong shareholder support. The company, a leader in LAG-3 immunotherapy for cancer and autoimmune diseases, continues to focus on advancing its innovative treatment options. This positive outcome is likely to strengthen investor confidence and potentially i...
No comment yet